SCHEMBL4787112

SCHEMBL4787112

COc1ccc(N=Cc2ccc(C#N)cc2)cc1.N#Cc1ccc(N=Cc2ccc(F)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 1/20 0.56
PTGS2 P35354 4/20 0.50
PTGS1 P23219 2/20 0.50
CA12 O43570 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
NFE2L2 Q16236 1/20 0.49
CA1 P00915 1/20 0.43
GAA P10253 4/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 5/20 0.42
LMNA P02545 3/20 0.42
KDM4E B2RXH2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787108 1.00 S100B (0.56) S100BPTGS2PTGS1CA12CA2
SCHEMBL295243 0.93 S100B (0.64) S100BPTGS2PTGS1CA12CA2
SCHEMBL2482983 0.93 S100B (0.64) S100BPTGS2PTGS1CA12CA2
SCHEMBL2482981 0.93 S100B (0.64) S100BPTGS2PTGS1CA12CA2
SCHEMBL3181342 0.93 S100B (0.64) S100BPTGS2PTGS1CA12CA2
SCHEMBL10413111 0.89 S100B (0.59) S100BPTGS2PTGS1CA12CA2
SCHEMBL10413110 0.89 S100B (0.59) S100BPTGS2PTGS1CA12CA2
SCHEMBL3198697 0.88 PTGS2 (0.53) PTGS2PTGS1CA12CA2CA9
SCHEMBL3190840 0.88 PTGS2 (0.53) PTGS2PTGS1CA12CA2CA9
SCHEMBL2909491 0.88 PTGS2 (0.53) PTGS2PTGS1CA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517890-B1 CATIONICALLY SUBSTITUTED DIPHENYL AZETIDINONES, METHOD FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF SANOFI AVENTIS DEUTSCHLAND (DE) 2008-07-16 EP disclosed
EP-1517890-A1 CATIONICALLY SUBSTITUTED DIPHENYL AZETIDINONES, METHOD FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2005-03-30 EP disclosed
WO-2004000803-A1 CATIONICALLY SUBSTITUTED DIPHENYL AZETIDINONES, METHOD FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-31 WO disclosed